Source: ERJ Open Res, 7 (3) 00198-2021; 10.1183/23120541.00198-2021
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Martin I. MacDonald, Christian R. Osadnik, Lauren Bulfin, Elizabeth Leahy, Paul Leong, Eskandarain Shafuddin, Kais Hamza, Paul T. King, Philip G. Bardin. MULTI-PHACET: multidimensional clinical phenotyping of hospitalised acute COPD exacerbations. ERJ Open Res, 7 (3) 00198-2021; 10.1183/23120541.00198-2021

Member's Comments

No comment yet.

Related content which might interest you: Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 An evaluation of exacerbations in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004 COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis Source: International Congress 2016 – Dealing with the complexity of critically-ill patients Year: 2016 COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020 Year: 2021 Phenotyping acute exacerbation of COPD: what more can we do for hospitalised patients? Source: ERJ Open Res, 7 (3) 00362-2021; 10.1183/23120541.00362-2021 Year: 2021 The validity of the EQ5D5L in patients hospitalized an acute exacerbation of COPD Source: International Congress 2017 – Latest insights into chronic care Year: 2017 Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. A comparative syudy Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Clinical pathway for acute COPD exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 64s Year: 2004 Hospitalization cost analysis due to acute COPD exacerbations Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016 Rehospitalizations for an acute exacerbation among patients with COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Gender differences in hospitalized patients with acute exacerbation of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 One year experience with acute COPD assessment service (ACAS) for patients with acute exacerbations of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 178s Year: 2006 Polypharmacy in patients hospitalised for acute exacerbation of COPD Source: Eur Respir J 2014; 44: 791-794 Year: 2014 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Detecting exacerbations using the clinical COPD questionnaire Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Acute management of COPD exacerbations Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview Year: 2012 Management of acute COPD exacerbations Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention Year: 2013